Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain

ABSTRACT Background Data from the sentinel surveillance system of severe acute respiratory infections in Spain were used to estimate the impact of administration of nirsevimab to children born from 1 April 2023 onwards. Methods Estimated RSV hospitalisations in

Saved in:
Bibliographic Details
Published in:Influenza and other respiratory viruses 2024-05, Vol.18 (5), p.e13294-n/a
Main Authors: Mazagatos, Clara, Mendioroz, Jacobo, Rumayor, Mercedes Belén, Gallardo García, Virtudes, Álvarez Río, Virginia, Cebollada Gracia, Ana Delia, Batalla Rebollo, Noa, Barranco Boada, María Isabel, Pérez‐Martínez, Olaia, Lameiras Azevedo, Ana Sofía, López González‐Coviella, Nieves, Castrillejo, Daniel, Fernández Ibáñez, Ana, Giménez Duran, Jaume, Ramírez Córcoles, Cristina, Ramos Marín, Violeta, Larrauri, Amparo, Monge, Susana, Basile, Luca, García Comas, Luis, Lorusso, Nicola, Pacheco Martínez, María del Carmen, Rodríguez Martí, Cristina, Linares Dópido, Juan Antonio, Sánchez‐Migallon Naranjo, Alonso, Otero‐Barrós, María Teresa, Lopez Torrijos, Miriam, Rivas Wagner, Eva, Hermoso Castro, Luisa F., Huerta Huerta, Marta, Reina Prieto, Jorge, Gómez Juárez, Ana, Ruiz Nuñez, Aranzazu, González Carril, Fernando, Imaz Goienetxea, Liher, Ibáñez Pérez, Ana Carmen, Berradre Saenz, Belén, Puma Olguin, Tania, Pérez Gimeno, Gloria, Galindo Carretero, Silvia, Vega Piris, Lorena, Lozano, Marcos
Format: Article
Language:English
Subjects:
Age groups
Antibodies
Antibodies, Monoclonal, Humanized - therapeutic use
Antiviral Agents - therapeutic use
Babies
burden
Child care
Childrens health
Disease prevention
Epidemiology
Female
Health care policy
Health surveillance
Hospitalization
Hospitalization - statistics & numerical data
Humans
impact
Incidence
Infant
Infant, Newborn
Infections
Male
Newborn babies
Pandemics
Pediatrics
Public health
respiratory infections
respiratory syncitial virus
Respiratory syncytial virus
Respiratory Syncytial Virus Infections - drug therapy
Respiratory Syncytial Virus Infections - epidemiology
Respiratory Syncytial Virus, Human
Respiratory tract infection
SARI
Seasons
Sentinel Surveillance
Short Communication
Short Communications
Spain - epidemiology
surveillance
Surveillance systems
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Background Data from the sentinel surveillance system of severe acute respiratory infections in Spain were used to estimate the impact of administration of nirsevimab to children born from 1 April 2023 onwards. Methods Estimated RSV hospitalisations in
ISSN:1750-2640
1750-2659
DOI:10.1111/irv.13294